Department of General, Visceral, Vascular and Pediatric Surgery, University of Saarland,
Homburg/Saar, D-66421, Germany
NCT Number: NCT00998907
The aim of this study is to ascertain if the use of PDS plus® reduces the number of wound infections and incisional hernia after midline and transverse laparotomy comparing to polyglactin suture.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Homburg/Saar, D-66421, Germany
All patients are treated using clinical pathways (CP) to standardise surgical procedures in our high volume centre. Part of the clinical process management was the standardisation of wound incision and abdominal wall closure.
Wound closure is achieved using continuous absorbable loop suture. The suture length to incision length ratio is at least 4:1. The running sutures are 1 cm apart and at least 1.5 cm from the wound edge. In the first time period , the CP step for fascia closure foresees a triclosan-coated PDS 910 loop suture (PDS plus®, Ethicon GmbH, Norderstedt, Germany). In the second time period the CP step will be altered to the use of PDS loop suture (PDS II®, Ethicon GmbH, Norderstedt, Germany). The CP- step is changed every 100 patients to cluster-randomize the patients. The primary outcome is the number of wound infections. Together with this the number of incisional hernia will be recorded. Patients demographic and disease as well as procedure related data are collected in a clinical information system (ISHmed on SAP platform, GSD, Berlin, Germany) prospectively. Risk factors for poor wound healing, such as operation time, patients age, sex, body mass index, blood loss, peritonitis, antibiotics, and performance level classified according to the American Society of Anesthesiologists (ASA), are collected prospectively to compare the two groups.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
triclosan-coated polydiaxanon 910 suture materials with antiseptic activity (PDS plus®, Ethicon GmbH, Norderstedt, Germany)
Other names: PDS plus®
polyglactin 910 suture material for abdominal wall closure
Time frame: 30 days after the operation
Time frame: 6 month
Time frame: 12 month
number of incisional hernia after 24 month
University Hospital, Saarland
Other
Pathway Driven Study to Evaluate the Incidence of Wound Infections and Incisional Hernias After Laparotomy and Fascial Closure With PDS*Plus Sutures
Acronym: PDS*plus
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04436887
Hernia, Incisional Hernia
View Trial DetailsNCT00508053
Hernia, Incisional Hernia
851 86 Sundsvall, Sweden
View Trial DetailsNCT06220058
Colonic Diseases, Colorectal Cancer
Girona, Catalonia, Spain
View Trial DetailsNCT01132209
Burst Abdomen, Hernia
Rotterdam, South Holland, Netherlands
View Trial Details